IDEAYA Biosciences, a precision oncology company, will hold an Investor R&D Day in London on November 16, 2026, to discuss its pancreatic cancer drug development strategy, including new preclinical data and combination therapies. The company will also participate in several investor conferences throughout September 2026, featuring fireside chats with its CEO and CFO. These events will be webcast live and available for replay, providing updates on IDEAYA's progress in targeted cancer therapies. This engagement highlights IDEAYA's commitment to advancing precision medicine and communicating its pipeline developments to investors.
Alphabet CEO Sundar Pichai revealed that the company is facing challenges in rapidly expanding its AI capacity to meet demand. Meanwhile, competitor Anthropic has successfully secured 5 gigawatts of AI computing power, highlighting a significant deve...
Graeter's Ice Cream partners with Toyota to introduce Salted Caramel Chip Wheels, a limited-edition ice cream treat featuring salted caramel ice cream between double chocolate chip cookies. This collaboration highlights the Toyota Sienna's FridgeBox™...
Bitcoin price retreated from around $81,300 to just below $78,000 after a strong 25% rally in August, showing signs of consolidation with weak directional momentum indicated by a low ADX reading. Resistance near $81,000–$82,000 and support around $75...
Four high-yield dividend stocks—Enterprise Products Partners, MPLX, Ares Capital, and Blue Owl Capital—offer yields above 6% and generate ordinary income taxed heavily in taxable accounts. Holding these stocks in a Roth IRA shelters the income from f...
Toyota's new RAV4, now sold only as a hybrid, is in high demand but limited supply has left dealers with only a few days' worth of inventory. This shortage is due to Toyota's initial limited production and a shift in buyer preference toward hybrids a...
